Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Mechanisms of in-stent restenosis after drug-eluting stent implantation: intravascular ultrasound analysis.

Kang SJ, Mintz GS, Park DW, Lee SW, Kim YH, Whan Lee C, Han KH, Kim JJ, Park SW, Park SJ.

Circ Cardiovasc Interv. 2011 Feb 1;4(1):9-14. doi: 10.1161/CIRCINTERVENTIONS.110.940320. Epub 2011 Jan 25.

2.

Predictors for functionally significant in-stent restenosis: an integrated analysis using coronary angiography, IVUS, and myocardial perfusion imaging.

Kang SJ, Cho YR, Park GM, Ahn JM, Han SB, Lee JY, Kim WJ, Park DW, Lee SW, Kim YH, Lee CW, Park SW, Mintz GS, Park SJ.

JACC Cardiovasc Imaging. 2013 Nov;6(11):1183-90. doi: 10.1016/j.jcmg.2013.09.006.

3.

Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.

Doi H, Maehara A, Mintz GS, Yu A, Wang H, Mandinov L, Popma JJ, Ellis SG, Grube E, Dawkins KD, Weissman NJ, Turco MA, Ormiston JA, Stone GW.

JACC Cardiovasc Interv. 2009 Dec;2(12):1269-75. doi: 10.1016/j.jcin.2009.10.005.

4.

Differences in tissue characterization of restenotic neointima between sirolimus-eluting stent and bare-metal stent: integrated backscatter intravascular ultrasound analysis for in-stent restenosis.

Ando H, Amano T, Takashima H, Harada K, Kitagawa K, Suzuki A, Kunimura A, Shimbo Y, Harada K, Yoshida T, Kato B, Uetani T, Kato M, Matsubara T, Kumagai S, Yoshikawa D, Isobe S, Ishii H, Murohara T.

Eur Heart J Cardiovasc Imaging. 2013 Oct;14(10):996-1001. doi: 10.1093/ehjci/jet003. Epub 2013 Jan 22.

PMID:
23341147
5.

A volumetric intravascular ultrasound comparison of early drug-eluting stent thrombosis versus restenosis.

Liu X, Doi H, Maehara A, Mintz GS, Costa Jde R Jr, Sano K, Weisz G, Dangas GD, Lansky AJ, Kreps EM, Collins M, Fahy M, Stone GW, Moses JW, Leon MB, Mehran R.

JACC Cardiovasc Interv. 2009 May;2(5):428-34. doi: 10.1016/j.jcin.2009.01.011.

6.

Long-term vascular changes after drug-eluting stent implantation assessed by serial volumetric intravascular ultrasound analysis.

Kang SJ, Park DW, Mintz GS, Lee SW, Kim YH, Lee CW, Han KH, Kim JJ, Park SW, Park SJ.

Am J Cardiol. 2010 May 15;105(10):1402-8. doi: 10.1016/j.amjcard.2009.12.064. Epub 2010 Apr 8.

PMID:
20451685
7.

Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation.

Song HG, Kang SJ, Ahn JM, Kim WJ, Lee JY, Park DW, Lee SW, Kim YH, Lee CW, Park SW, Park SJ.

Catheter Cardiovasc Interv. 2014 May 1;83(6):873-8. doi: 10.1002/ccd.24560. Epub 2013 Nov 9.

PMID:
22815193
8.

Comparative efficacy of gamma-irradiation for treatment of in-stent restenosis in saphenous vein graft versus native coronary artery in-stent restenosis: An intravascular ultrasound study.

Castagna MT, Mintz GS, Waksman R, Ahmed JM, Maehara A, Ajani AE, Bui AB, Satler LF, Suddath WO, Kent KM, Pichard AD, Weissman NJ.

Circulation. 2001 Dec 18;104(25):3020-2.

9.

Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation.

Takebayashi H, Mintz GS, Carlier SG, Kobayashi Y, Fujii K, Yasuda T, Costa RA, Moussa I, Dangas GD, Mehran R, Lansky AJ, Kreps E, Collins MB, Colombo A, Stone GW, Leon MB, Moses JW.

Circulation. 2004 Nov 30;110(22):3430-4. Epub 2004 Nov 22.

10.
11.

Angiographic patterns of restenosis after percutaneous intervention of chronic total occlusive lesions with drug-eluting stents.

Lee SP, Shin DH, Park KW, Kang HJ, Koo BK, Cho YS, Yeon TJ, Chae IH, Choi DJ, Kim HS.

Int J Cardiol. 2012 Apr 19;156(2):180-5. doi: 10.1016/j.ijcard.2010.10.138. Epub 2010 Nov 24.

PMID:
21109317
12.

Comprehensive intravascular ultrasound assessment of stent area and its impact on restenosis and adverse cardiac events in 403 patients with unprotected left main disease.

Kang SJ, Ahn JM, Song H, Kim WJ, Lee JY, Park DW, Yun SC, Lee SW, Kim YH, Lee CW, Mintz GS, Park SW, Park SJ.

Circ Cardiovasc Interv. 2011 Dec 1;4(6):562-9. doi: 10.1161/CIRCINTERVENTIONS.111.964643. Epub 2011 Nov 1.

13.

Mechanisms of balloon angioplasty and repeat stenting in patients with drug-eluting in-stent restenosis.

Alfonso F, Sandoval J, Pérez-Vizcayno MJ, Cárdenas A, Gonzalo N, Jiménez-Quevedo P, Ibáñez B, Núñez-Gil I, Rivero F, Escaned J, Fernández-Ortíz A, Macaya C.

Int J Cardiol. 2015 Jan 15;178:213-20. doi: 10.1016/j.ijcard.2014.10.139. Epub 2014 Oct 23.

PMID:
25464257
14.

Volumetric intravascular ultrasound assessment of neointimal hyperplasia and nonuniform stent strut distribution in sirolimus-eluting stent restenosis.

Sano K, Mintz GS, Carlier SG, Fujii K, Takebayashi H, Kimura M, Costa JR Jr, Tanaka K, Costa RA, Lui J, Weisz G, Moussa I, Dangas GD, Mehran R, Lansky AJ, Kreps EM, Collins M, Stone GW, Moses JW, Leon MB.

Am J Cardiol. 2006 Dec 15;98(12):1559-62. Epub 2006 Oct 17.

PMID:
17145209
15.

An intravascular ultrasound analysis of the mechanisms of restenosis comparing drug-eluting stents with brachytherapy.

Kim SW, Mintz GS, Escolar E, Ohlmann P, Pregowski J, Tyczynski P, Hassani SE, Pichard AD, Satler LF, Kent KM, Suddath WO, Waksman R, Weissman NJ.

Am J Cardiol. 2006 May 1;97(9):1292-8. Epub 2006 Mar 13.

PMID:
16635598
16.

The contribution of "mechanical" problems to in-stent restenosis: An intravascular ultrasonographic analysis of 1090 consecutive in-stent restenosis lesions.

Castagna MT, Mintz GS, Leiboff BO, Ahmed JM, Mehran R, Satler LF, Kent KM, Pichard AD, Weissman NJ.

Am Heart J. 2001 Dec;142(6):970-4.

PMID:
11717599
17.

Arterial remodeling patterns before intervention predict diffuse in-stent restenosis: an intravascular ultrasound study.

Sahara M, Kirigaya H, Oikawa Y, Yajima J, Ogasawara K, Satoh H, Nagashima K, Hara H, Nakatsu Y, Aizawa T.

J Am Coll Cardiol. 2003 Nov 19;42(10):1731-8.

19.

The role of integrated backscatter intravascular ultrasound in characterizing bare metal and drug-eluting stent restenotic neointima as compared to optical coherence tomography.

Sato K, Costopoulos C, Takebayashi H, Naganuma T, Miyazaki T, Goto K, Yamane H, Hagikura A, Kikuta Y, Taniguchi M, Hiramatsu S, Ito H, Colombo A, Haruta S.

J Cardiol. 2014 Dec;64(6):488-95. doi: 10.1016/j.jjcc.2014.03.007. Epub 2014 Apr 29.

20.

Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis.

Fujii K, Mintz GS, Kobayashi Y, Carlier SG, Takebayashi H, Yasuda T, Moussa I, Dangas G, Mehran R, Lansky AJ, Reyes A, Kreps E, Collins M, Colombo A, Stone GW, Teirstein PS, Leon MB, Moses JW.

Circulation. 2004 Mar 9;109(9):1085-8. Epub 2004 Mar 1.

Supplemental Content

Support Center